Analyst Ratings for Actuate Therapeutics (ACTU)
ACTU Rating Summary
ACTU Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.80 (+1055.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$17.80 (+1055.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/30/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.08 (1.54) |
42.59% | Details |
| 8/26/2025 | B.Riley » Updated 4/15/2026 |
Mayank Mamtani | New Coverage | Buy (N/A) |
8.00 (20.00) |
8.36 (1.54) |
-81.58% | Details |
 |
||||||||
|
||||||||
